{"brief_title": "Pilot Study of Vedic Medicine for Type 2 Diabetes", "brief_summary": "The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.", "detailed_description": "Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.", "condition": ["Diabetes Mellitus, Type 2"], "intervention_type": ["Drug", "Behavioral"], "intervention_name": ["Vedic Medicine", "Vedic Medicine"], "criteria": "Inclusion criteria: - Kaiser Permanente members - Newly diagnosed type 2 Diabetes - Baseline glycosylated hemoglobin level of 6.0-7.9. Exclusion criteria: - Pregnancy or nursing mother - Currently taking warfarin - Diagnosis of psychotic disorder or recent hospitalization for depression - Unable to comply with or attend treatment sessions", "gender": "All", "minimum_age": "25 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "keyword": "Transcendental Meditation", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2"], "id": "NCT00065650"}